3-158644562-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_024996.7(GFM1):c.-73C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0028 in 1,280,288 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 50 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 30 hom. )
Consequence
GFM1
NM_024996.7 5_prime_UTR
NM_024996.7 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.170
Genes affected
GFM1 (HGNC:13780): (G elongation factor mitochondrial 1) Eukaryotes contain two protein translational systems, one in the cytoplasm and one in the mitochondria. Mitochondrial translation is crucial for maintaining mitochondrial function and mutations in this system lead to a breakdown in the respiratory chain-oxidative phosphorylation system and to impaired maintenance of mitochondrial DNA. This gene encodes one of the mitochondrial translation elongation factors. Its role in the regulation of normal mitochondrial function and in different disease states attributed to mitochondrial dysfunction is not known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 3-158644562-C-T is Benign according to our data. Variant chr3-158644562-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 343917.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0128 (1955/152324) while in subpopulation AFR AF= 0.0448 (1861/41572). AF 95% confidence interval is 0.0431. There are 50 homozygotes in gnomad4. There are 947 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 50 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GFM1 | NM_024996.7 | c.-73C>T | 5_prime_UTR_variant | 1/18 | ENST00000486715.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GFM1 | ENST00000486715.6 | c.-73C>T | 5_prime_UTR_variant | 1/18 | 1 | NM_024996.7 | P1 | ||
GFM1 | ENST00000478576.5 | c.-73C>T | 5_prime_UTR_variant | 1/14 | 2 | ||||
GFM1 | ENST00000478254.5 | c.-73C>T | 5_prime_UTR_variant, NMD_transcript_variant | 1/18 | 5 | ||||
GFM1 | ENST00000264263.9 | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1947AN: 152206Hom.: 50 Cov.: 32
GnomAD3 genomes
AF:
AC:
1947
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00145 AC: 1633AN: 1127964Hom.: 30 Cov.: 15 AF XY: 0.00130 AC XY: 736AN XY: 566654
GnomAD4 exome
AF:
AC:
1633
AN:
1127964
Hom.:
Cov.:
15
AF XY:
AC XY:
736
AN XY:
566654
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0128 AC: 1955AN: 152324Hom.: 50 Cov.: 32 AF XY: 0.0127 AC XY: 947AN XY: 74494
GnomAD4 genome
AF:
AC:
1955
AN:
152324
Hom.:
Cov.:
32
AF XY:
AC XY:
947
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at